Light Chain Bioscience (Switzerland)

Light Chain Bioscience (Switzerland)

Novimmune is a privately held Swiss pharmaceutical development company focusing on monoclonal antibody therapies for treatment of immune-related diseases. The company was founded in 1998. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Light Chain Bioscience (Switzerland), Switzerland, covering academic research published from 2002 to 2024. Read More.


Open Access Percentage

62%


Total
Publications

302


Total Open
Publications

186


Total
Citations

16K


Open Access
Percentage

62%


Total
Publications

302


Total Open
Publications

186


Total
Citations

16K

Wikipedia

Website

download

Breakdown

23% 34% 4% 39%

Publisher Open

23%

Both

34%

Other Platform Open

4%

Closed

39%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214161820222426Total Publications
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

57%OA Journal

OA Journal 57%

97

Hybrid 9%

16

No Guarantees 34%

57

Other Platform Open

Domain 80%

93

Institution 30%

35

Other Internet 22%

26

Public 4%

5

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
92
DOI
Other Internet
27
Europe PMC
Domain
8
ETH Zurich - Repository for Publications and Research Data
Institution
6
DANS - Data Archiving and Networked Services
Institution
5
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
4
Figshare
Public
4
Sapienza University of Rome - IRIS Research product catalog
Institution
3
University of Geneva - Archive ouverte UNIGE
Institution
2
Elsevier - Scopus
Institution
2
1 / 4

Data updated 18 August 2025

Share

Share

Share